
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7089649
[patent_doc_number] => 20050009762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Application of water and organic solvent soluble ivermectin for topical and oral use'
[patent_app_type] => utility
[patent_app_number] => 10/806683
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3128
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10806683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/806683 | Application of water and organic solvent soluble ivermectin for topical and oral use | Jun 5, 2003 | Abandoned |
Array
(
[id] => 727499
[patent_doc_number] => RE039087
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof'
[patent_app_type] => reissue
[patent_app_number] => 10/454586
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2227
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454586 | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof | Jun 4, 2003 | Issued |
Array
(
[id] => 1126904
[patent_doc_number] => 06790835
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-14
[patent_title] => 'Bicyclic macrolide derivatives'
[patent_app_type] => B1
[patent_app_number] => 10/455219
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22663
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 707
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/790/06790835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455219 | Bicyclic macrolide derivatives | Jun 4, 2003 | Issued |
Array
(
[id] => 1205880
[patent_doc_number] => 06716820
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-06
[patent_title] => '6-O-substituted bicyclic macrolides'
[patent_app_type] => B1
[patent_app_number] => 10/455001
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14814
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455001 | 6-O-substituted bicyclic macrolides | Jun 4, 2003 | Issued |
Array
(
[id] => 1147313
[patent_doc_number] => 06774115
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => '6-O-substituted bicyclic ketolides'
[patent_app_type] => B1
[patent_app_number] => 10/454865
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23854
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/774/06774115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454865 | 6-O-substituted bicyclic ketolides | Jun 4, 2003 | Issued |
Array
(
[id] => 769285
[patent_doc_number] => 07005421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-28
[patent_title] => 'Injectable ready-to-use solutions containing an antitumor anthracycline glycoside'
[patent_app_type] => utility
[patent_app_number] => 10/454275
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8300
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005421.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454275
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454275 | Injectable ready-to-use solutions containing an antitumor anthracycline glycoside | Jun 3, 2003 | Issued |
Array
(
[id] => 7020033
[patent_doc_number] => 20050222052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Process for preparing high purity azithromycin'
[patent_app_type] => utility
[patent_app_number] => 10/516719
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2309
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222052.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516719
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516719 | Process for preparing high purity azithromycin | Jun 3, 2003 | Abandoned |
Array
(
[id] => 1175825
[patent_doc_number] => 06747011
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-08
[patent_title] => 'Antitumor drugs and methods'
[patent_app_type] => B1
[patent_app_number] => 10/453921
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12134
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/747/06747011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10453921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/453921 | Antitumor drugs and methods | Jun 3, 2003 | Issued |
Array
(
[id] => 7448794
[patent_doc_number] => 20040009930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Macrolide antibiotics'
[patent_app_type] => new
[patent_app_number] => 10/454354
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17792
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454354 | Macrolide antibiotics | Jun 2, 2003 | Issued |
Array
(
[id] => 701156
[patent_doc_number] => 07063862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-20
[patent_title] => 'Pharmaceutical composition and method for treating'
[patent_app_type] => utility
[patent_app_number] => 10/454240
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5087
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/063/07063862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454240
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454240 | Pharmaceutical composition and method for treating | Jun 2, 2003 | Issued |
Array
(
[id] => 7314957
[patent_doc_number] => 20040034203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Polyol-modified silanes as precursors for silica'
[patent_app_type] => new
[patent_app_number] => 10/449511
[patent_app_country] => US
[patent_app_date] => 2003-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14616
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10449511
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/449511 | Polyol-modified silanes as precursors for silica | Jun 1, 2003 | Abandoned |
Array
(
[id] => 7398377
[patent_doc_number] => 20040039010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Methods for treatment of acute lymphocytic leukemia'
[patent_app_type] => new
[patent_app_number] => 10/453056
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17166
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10453056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/453056 | Methods for treatment of acute lymphocytic leukemia | May 29, 2003 | Issued |
Array
(
[id] => 993692
[patent_doc_number] => 06916791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Androgen derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/452004
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7578
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10452004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/452004 | Androgen derivatives and uses thereof | May 29, 2003 | Issued |
Array
(
[id] => 1093103
[patent_doc_number] => 06825172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => '3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents'
[patent_app_type] => B2
[patent_app_number] => 10/447058
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31249
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447058 | 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents | May 27, 2003 | Issued |
Array
(
[id] => 7361813
[patent_doc_number] => 20040014695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Pharmaceutical formulation'
[patent_app_type] => new
[patent_app_number] => 10/447299
[patent_app_country] => US
[patent_app_date] => 2003-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13300
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014695.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447299 | Pharmaceutical formulation | May 26, 2003 | Abandoned |
Array
(
[id] => 1143078
[patent_doc_number] => 06777543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-17
[patent_title] => '13-methyl erythromycin derivatives'
[patent_app_type] => B2
[patent_app_number] => 10/441347
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25840
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441347
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441347 | 13-methyl erythromycin derivatives | May 18, 2003 | Issued |
Array
(
[id] => 707870
[patent_doc_number] => 07060685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Compounds and methods for inhibiting selectin-mediated function'
[patent_app_type] => utility
[patent_app_number] => 10/440476
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8173
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10440476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/440476 | Compounds and methods for inhibiting selectin-mediated function | May 15, 2003 | Issued |
Array
(
[id] => 6702148
[patent_doc_number] => 20030225028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Beta-L-2\'deoxy-nucleosides for the treatment of hepatitis B'
[patent_app_type] => new
[patent_app_number] => 10/438167
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17453
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225028.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438167 | Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B | May 12, 2003 | Abandoned |
Array
(
[id] => 7297233
[patent_doc_number] => 20040214782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Treatment or prevention of coccidiosis'
[patent_app_type] => new
[patent_app_number] => 10/437312
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4838
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437312
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437312 | Treatment or prevention of coccidiosis | May 12, 2003 | Abandoned |
Array
(
[id] => 7361762
[patent_doc_number] => 20040014684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Hepatoprotective activity of 2\'-p-hydroxybenzoylmussaenosidic'
[patent_app_type] => new
[patent_app_number] => 10/436321
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2820
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10436321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/436321 | Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid | May 11, 2003 | Issued |